Relationship between Apparent Diffusion Coefficient Distribution and Cancer Grade in Prostate Cancer and Benign Prostatic Hyperplasia

被引:8
|
作者
Saito, Shigeyoshi [1 ,2 ]
Koyama, Yoshihiro [3 ]
Ueda, Junpei [1 ]
Hashido, Takashi [3 ]
机构
[1] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Med Phys & Engn, Osaka 5650871, Japan
[2] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Adv Med Technol, Osaka 5650871, Japan
[3] Osaka Univ Hosp, Dept Med Technol, Div Radiol, Osaka 5648565, Japan
基金
日本学术振兴会;
关键词
histogram-derived ADC parameters; stromal hyperplasia; glandular hyperplasia; prostate cancer; benign prostate hyperplasia; CONTRAST-ENHANCED MRI; LOCAL TREATMENT; GLEASON SCORE; NORMAL TISSUE; GUIDELINES; DIAGNOSIS; DIFFERENTIATION; CELLULARITY; UPDATE; BIOPSY;
D O I
10.3390/diagnostics12020525
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this paper was to assess the associations between prostate cancer aggressiveness and histogram-derived apparent diffusion coefficient (ADC) parameters and determine which ADC parameters may help distinguish among stromal hyperplasia (SH), glandular hyperplasia (GH), and low-grade, intermediate-grade, and high-grade prostate cancers. The mean, median, minimum, maximum, and 10th and 25th percentile ADC values were determined from the ADC histogram and compared among two benign prostate hyperplasia (BPH) groups and three Gleason score (GS) groups. Seventy lesions were identified in 58 patients who had undergone proctectomy. Thirty-nine lesions were prostate cancers (GS 6 = 7 lesions, GS 7 = 19 lesions, GS 8 = 11 lesions, GS 9 = 2 lesions), and thirty-one lesions were BPH (SH = 15 lesions, GH = 16 lesions). There were statistically significant differences in 10th percentile and 25th percentile ADC values when comparing GS 6 to GS 7 (p < 0.05). The 10th percentile ADC values yielded the highest area under the curve (AUC). Tenth and 25th percentile ADCs can be used to more accurately differentiate lesions with GS 6 from those with GS 7 than other ADC parameters. Our data indicate that the major challenge with ADC mapping is to differentiate between SH and GS 6, and SH and GS 7.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Androgen Receptor Expression In Benign Prostatic Hyperplasia And Prostate Cancer
    Putriyuni, Anandia
    Liana, Nana
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2023, 30 (05): : E430 - E436
  • [42] Associations of Benign Prostatic Hyperplasia With Prostate Cancer: The Debate Continues
    Kopp, Ryan P.
    Freedland, Stephen J.
    Parsons, J. Kellogg
    EUROPEAN UROLOGY, 2011, 60 (04) : 699 - 700
  • [43] Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia
    Yu, Haining
    Meng, Hongzhou
    Zhou, Feng
    Ni, Xiaofeng
    Shen, Shengrong
    Das, Undurti N.
    ARCHIVES OF MEDICAL SCIENCE, 2015, 11 (02) : 385 - 394
  • [44] DIAGNOSING BENIGN PROSTATIC HYPERPLASIA VERSUS PROSTATE-CANCER
    DENIS, LJ
    BRITISH JOURNAL OF UROLOGY, 1995, 76 : 17 - 23
  • [45] Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer
    Ratajczak, Weronika
    Lubkowski, Michal
    Lubkowska, Anna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (02)
  • [46] Potential biomarkers for differentiation of benign prostatic hyperplasia and prostate cancer
    El Melegy, N. T.
    Aboulella, H. A.
    Abul-Fadl, A. M.
    Mohamed, N. A.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2010, 67 (03) : 109 - 112
  • [47] Is garlic a promising food for benign prostatic hyperplasia and prostate cancer?
    Devrim, Erdinc
    Durak, Ilker
    MOLECULAR NUTRITION & FOOD RESEARCH, 2007, 51 (11) : 1319 - 1323
  • [48] Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer
    Cicero, Arrigo F. G.
    Allkanjari, Olta
    Busetto, Gian Maria
    Cai, Tommaso
    Largana, Gaetano
    Magri, Vittorio
    Perletti, Gianpaolo
    Della Cuna, Francesco Saverio Robustelli
    Russo, Giorgio Ivan
    Stamatiou, Kostantinos
    Trinchieri, Alberto
    Vitalone, Annabella
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2019, 91 (03) : 139 - 152
  • [49] Inflammation and endothelial activation in Benign Prostatic Hyperplasia and Prostate Cancer
    Pace, Gianna
    Di Massimo, Caterina
    De Amicis, Daniela
    Vicentini, Carlo
    Ciancarelli, M. Giuliana Tozzi
    INTERNATIONAL BRAZ J UROL, 2011, 37 (05): : 617 - 622
  • [50] Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer
    Glaser, Alexander
    Shi, Zhuqing
    Wei, Jun
    Lanman, Nadia A.
    Ladson-Gary, Skylar
    Vickman, Renee E.
    Franco, Omar E.
    Crawford, Susan E.
    Zheng, S. Lilly
    Hayward, Simon W.
    Isaacs, William B.
    Helfand, Brian T.
    Xu, Jianfeng
    EUROPEAN UROLOGY OPEN SCIENCE, 2022, 43 : 54 - 61